of Gynaecology and Obstetrics now wants to clarify in a study whether such a self-test for home use can better reach the risk group. The study is part of the prevention programme of the Comprehensive [...] lecturer Dr Matthias Jentschke, head of the study and managing senior physician at the Department of Gynaecology and Obstetrics at MHH. "We hope that the study will motivate women in particular who have [...] the Minister. The active phase of the self-collection study will last until summer 2022, after which it is The active phase of the self-collection study will last until summer 2022, after which initial results

the pilot study ORION-HF. The intake of tablets would be better for patients to implement in their daily lives than the administration of iron by infusion. MHH cardiology is coordinating the study, and other [...] have a much better quality of life. Study with 50 subjects At ORION-HF, the Department of Cardiology and Angiology works closely with the Center for Clinical Studies of the MHH. A total of 50 patients with [...] deficiency and anemia are enrolled in the study. For a period of 16 weeks, the subjects take an iron tablet in the morning and in the evening. Afterwards, the study doctors examine the effect. “If it turns

KEYNOTE-966 study was the largest global study ever conducted in biliary tumours. The KEYNOTE-966 Phase 3 trial was conducted at 175 medical centres worldwide and included 1,069 patients. Study participants [...] KEYNOTE-966 study that the overall survival of patients is improved with the addition of the immune checkpoint inhibitor pembrolizumab. The results were published in the journal The Lancet. "Our study shows [...] Gastroenterology, Hepatology, Infectious Diseases and Endocrinology and corresponding last author of the study. "Pembrolizumab plus gemcitabine and cisplatin represents a new treatment option in first-line treatment

(MHH). Statewide, 60 study places have been reserved. All three medical faculties in Lower Saxony are accepting students via the preliminary quota, and the MHH is making 18 study places available. With [...] (NiZzA) until the end of March. This does not result in any additional study places. Via the so-called advance quota, 2.2 percent of all study places are also reserved for medical officers in the German Armed [...] themselves to working as a family doctor in an underserved region for ten years after completing their studies. Central application and selection procedure via (NiZzA) The application and selection process will

follows. Genome of the child and parents is decoded This is precisely where the Baby Lion study comes in, the first study of its kind in German-speaking countries. "Today, it is possible to completely decode [...] by a team from Pediatrics and Human Genetics at Hannover Medical School (MHH) in the "Baby Lion" study. The focus is on decoding the genome, i.e. the entire genetic information of a human being, in just [...] disease is not so rare after all," says Dr. Bernd Auber of the Institute of Human Genetics. For the study, he and his team are focusing on a special patient group: children in their first weeks and -months

the PLRI. The lecturers of the PLRI are substantially involved in the teaching of the study programme. The right study programme in the right place at the right time " The MHH is a very good place to combine [...] place at the right time." MHH Dean of Studies Prof. Dr. Ingo Just pointed out that the students have a medical or a natural science background and that the study programme thus prepares them very well [...] Informatics (PLRI) of the MHH and the TU Braunschweig. The first 18 students have now started their studies. They are graduates of a life science bachelor's degree or a medical degree. In the coming four semesters

symptoms sought The DGfN has been calling for controlled studies on the benefits of the therapy for some time. "In contrast to previous case studies, our approach meets precisely this requirement and thus [...] ion in the "EXTINCT post COVID" study. Patients with post-COVID syndrome who suffer from chronic fatigue syndrome are being sought. For more information about the study and conditions of participation [...] Hannover , it is investigating the therapeutic efficacy of immunoadsorption in post-COVID sufferers. The study "EXTINCT post COVID" is funded by the state of Lower Saxony within the framework of the COVID-19 Research

PD Dr. Stahl. More than 20 study centres "The new treatment strategy is safe and has the potential to provide potentially significant benefits for patients. In the new study, we want to find out in a [...] Germany, Switzerland and Austria with about 270 patients are participating in the international study. The study is led by the team of the "Translational Intensive Care Medicine" working group around Professor [...] the Hannover Medical School (MHH) wants to investigate a new treatment strategy in a multicentre study. The focus is on therapeutic plasma exchange. The scientists want to find out whether the new treatment

register ASPIRE. The study leader is Professor Dr Marius Hoeper, Vice Director of the Department of Pneumology. Researchers compared three different patient groups In the study, the team compared three [...] pulmonary hypertension. The term "idiopathic" means that there is no tangible cause for the disease. A study group led by the Department of Pneumology at the Hannover Medical School (MHH) has now taken a decisive [...] forms of pulmonary hypertension is increasing shortness of breath during physical exertion. For their study, the researchers used data from the COMPERA pulmonary hypertension register, one of the largest registers

MHH CoCo study "The work is once again a great team success and the result of the CoCo study, which is made possible and supported by MHH employees," emphasises Professor Behrens. The CoCo study started [...] Omikron subline XBB.1.5. However, the effectiveness of the new boosters has not yet been proven. A study by the Department of Rheumatology and Immunology at Hannover Medical School (MHH) has now closed this [...] first paper on the new XBB.1.5-based vaccine from Biontech. As part of the "COVID-19 Contact (CoCo)" study at the MHH, 53 MHH employees who received the vaccine were examined. Their immune response was then